Assistant Professor, Otolaryngology
News and Stories
Two subtypes of HPV-associated head and neck cancers predict treatment outcomes
Researchers have divided HPV+ head and neck cancers into two distinct subtypes, which can help determine how well patients will respond to therapy.
Protein could help identify head and neck cancers that require less intensive treatment
Adding detection of immune cell protein SYNGR3 to current protocols could lead to a more reliable way of determining which patients with head and neck cancer need less intensive treatment.